CITADEL ADVISORS LLC cut 93% of RXRX (2026Q2)HIGHSHORTSep 6
Bridgewater Associates, LP new position in RXRXMEDIUMLONGSep 6
CITADEL ADVISORS LLC cut 93% of RXRX (2026Q2)HIGHSHORTSep 6
Bridgewater Associates, LP new position in RXRXMEDIUMLONGSep 6
CITADEL ADVISORS LLC cut 93% of RXRX (2026Q2)HIGHSHORTAug 16
Bridgewater Associates, LP new position in RXRXMEDIUMLONGAug 16
Bridgewater Associates, LP new position in RXRXMEDIUMLONGAug 16
Q4-2025: Beat consensus by 34.8% - EPS $-0.21 vs $-0.322 estimateMEDIUMLONGJun 20